| European Case Law Identifier: | ECLI:EP:BA:1994:T029693.19940728 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 28 July 1994 | ||||||||
| Case number: | T 0296/93 | ||||||||
| Application number: | 85201908.2 | ||||||||
| IPC class: | C12N 15/51 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | A | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Recombinant DNA molecules and their method of production | ||||||||
| Applicant name: | BIOGEN. INC. | ||||||||
| Opponent name: | (01) INTERNATIONAL MUREX TECHNOLOGIES CORPORATION (02) Institut Pasteur Etablissement public (03) IMMUNO Aktiengesellschaft (04) Hexal-Biotech GmbH (05) Medeva PLC |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | The applicable starting point for calculating the three month period for intervention under Article 105(1) EPC is always the date of the institution of the first court action. Where a court action for infringement was first brought by a patentee against an alleged infringer, Article 105(1) EPC first sentence applies, even though the latter later instituted a court action seeking a declaration of non-infringement under Article 105(1) EPC second sentence, with regard to the same patent. | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Admissibility of intervention of assumed infringer (no) - too late Entitlement to priority (yes) - same invention Citability of prior art document (no) Novelty (yes) Inventive step (yes) Enlarged Board - referral (no) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: | |||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t930296ex1.html
Date retrieved: 17 May 2021
51 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.Offical Journal of the EPO
XOJ EPO SE 1/2021, p179 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2020)
XOJ EPO SE 1/2020, p174 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2019)
XOJ EPO SE 1/2019, p158 - XVI. - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2018)
Case Law Book: I Patentability
Case Law Book: II Conditions to be met by an Application
XCLR II D 3.1.5 Explicit or implicit disclosure of the features of the invention in the priority document